imclone systems founder sam waksal on drug pricing
Published 4 years ago • 643 plays • Length 4:04Download video MP4
Download video MP3
Similar videos
-
5:29
watch cnbc's full interview with imclone systems founder sam waksal
-
7:16
how one company is trying to undercut drug pricing
-
4:32
watch cnbc's full interview with regeneron ceo len schleifer
-
4:14
data centers will be driver business for prologis, says ceo hamid moghadam
-
4:17
china is having to build a semiconductor industry from old machines, analyst says
-
37:16
i have exciting (and terrible) news
-
5:57
three buys and a bail: microsoft, amd, caterpillar, & enphase
-
6:39
global tech outage disrupts businesses, flights
-
0:46
samsung electronics to manufacture ibm's new enterprise hybrid cloud processor chip
-
4:44
prosecutors request gag order in 'pharma bro' martin shkreli trial | cnbc
-
5:50
asml pullback shouldn't worry investors: analyst
-
0:32
iguazio ceo, asaf somekh, live on cnbc - iiot
-
22:57
aws summit asean 2022 - petronas: journey towards becoming a cloud-first company (ind102)
-
1:34
drug prices increase despite trump's plan to cut costs
-
1:53
how kidney care companies could be affected by trump's executive order
-
11:14
coronavirus: why testing for antibodies is crucial
-
2:35
shane mcardle explains the importance of linking the digital twin to business value
-
1:16
the team who created amazon's warehouse robots returns with a new robot named chuck | cnbc
-
1:59
are new migraine drugs causing a headache to investors?
-
1:36
sme instrument champion immunovia starts floating on the stock exchange
-
1:28
u.k. tech giant sold for $32b
-
1:31
a.i. to top tech spending at many companies: cnbc survey